Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B
Authors
Keywords
-
Journal
PHYTOMEDICINE
Volume 111, Issue -, Pages 154669
Publisher
Elsevier BV
Online
2023-01-13
DOI
10.1016/j.phymed.2023.154669
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Apoptosis in Cancer
- (2022) Puneet Singh et al. Current Oncology Reports
- Therapeutic strategies to overcome cisplatin resistance in ovarian cancer
- (2022) Mengdi Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Crosstalk between RNA viruses and DNA sensors: Role of the cGAS‐STING signalling pathway
- (2022) Yiyun Michelle Fan et al. REVIEWS IN MEDICAL VIROLOGY
- A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer
- (2022) Pierina Cetraro et al. Cancers
- Cucurbitacin B Down-Regulates TNF Receptor 1 Expression and Inhibits the TNF-α-Dependent Nuclear Factor κB Signaling Pathway in Human Lung Adenocarcinoma A549 Cells
- (2022) Eiichi Kusagawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
- (2022) Tingting Chen et al. International Journal of Nanomedicine
- Gene Ontology Capsule GAN: an improved architecture for protein function prediction
- (2022) Musadaq Mansoor et al. PeerJ Computer Science
- Recurrent Ovarian Cancer with BRCAness Phenotype: A Treatment Challenge
- (2022) Cláudia Caeiro et al. ADVANCES IN THERAPY
- Nanodelivery of cGAS-STING activators for tumor immunotherapy
- (2022) Jianfeng Guo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis
- (2021) Renyikun Yuan et al. PHARMACOLOGICAL RESEARCH
- Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
- (2021) Claudia Marchetti et al. SEMINARS IN CANCER BIOLOGY
- Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
- (2021) Jinglin Zhu et al. Cancer Cell International
- Vorinostat targets UBE2C to reverse epithelial-mesenchymal transition and control cervical cancer growth through the ubiquitination pathway
- (2021) Botao Pan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer
- (2021) Haoyue Zhang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity
- (2020) Jiaxin Xu et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells
- (2020) Chenglai Xia et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- iTRAQ-based quantitative proteomic analysis of Colletotrichum lini reveals ethanol induced mechanism for enhancing dihydroxylation efficiency of DHEA
- (2020) Hui Li et al. Journal of Proteomics
- High-throughput, Label-Free Quantitative Proteomic Studies of the Anticancer Effects of Electrical Pulses with Turmeric Silver Nanoparticles: an in vitro Model Study
- (2020) Lakshya Mittal et al. Scientific Reports
- Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer
- (2020) Tzu-Ting Huang et al. CANCER TREATMENT REVIEWS
- Targeting mitosis exit: A brake for cancer cell proliferation
- (2019) Xinran Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
- (2019) Devesh Tewari et al. SEMINARS IN CANCER BIOLOGY
- Label-free based quantitative proteomic analysis identifies proteins involved in the testis maturation of Bactrocera dorsalis (Hendel)
- (2018) Dong Wei et al. Comparative Biochemistry and Physiology D-Genomics & Proteomics
- Cell-impedance-based label-free technology for the identification of new drugs
- (2017) Kenneth Lundstrom Expert Opinion on Drug Discovery
- Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model
- (2017) Lucas Lourenço Marostica et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells
- (2017) Yingchun Qu et al. Oncology Letters
- BlastKOALA and GhostKOALA: KEGG Tools for Functional Characterization of Genome and Metagenome Sequences
- (2016) Minoru Kanehisa et al. JOURNAL OF MOLECULAR BIOLOGY
- Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/Adriamycin cells
- (2016) Fen Cai et al. ONCOLOGY REPORTS
- Precision medicine: from pharmacogenomics to pharmacoproteomics
- (2016) Allison B. Chambliss et al. Clinical Proteomics
- Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells
- (2015) Yuqi Sun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
- (2015) Seiji Mabuchi et al. GYNECOLOGIC ONCOLOGY
- Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells
- (2015) Guowen Ren et al. Journal of Natural Medicines
- Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs
- (2014) Yubo Guo et al. JOURNAL OF ETHNOPHARMACOLOGY
- Cucurbitacin B Induced ATM-Mediated DNA Damage Causes G2/M Cell Cycle Arrest in a ROS-Dependent Manner
- (2014) Jiajie Guo et al. PLoS One
- Large-scale label-free phosphoproteomics: from technology to data interpretation
- (2014) Hongbo Guo et al. Bioanalysis
- Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α
- (2013) Juan Ma et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Biological activities and potential molecular targets of cucurbitacins
- (2012) Xiuping Chen et al. ANTI-CANCER DRUGS
- Cancer proteomics
- (2012) Hwee Tong Tan et al. MASS SPECTROMETRY REVIEWS
- Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature
- (2011) Krystyna Serkies et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- DIGE and iTRAQ as biomarker discovery tools in aquatic toxicology
- (2011) Christopher J. Martyniuk et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Hot Topics in Chinese Herbal Drugs Research Documented in PubMed/MEDLINE® by Authors Inside China and Outside of China in the Past 10 Years: Based on Co-Word Cluster Analysis
- (2009) Hai-Yan Li et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started